Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report

MLA

Giulia Bianchi, et al. “Prolonged Benefit from Palbociclib plus Letrozole in Heavily Pretreated Advanced Male Breast Cancer: Case Report.” Tumori Journal, vol. 107, Dec. 2020, pp. NP15-NP19. EBSCOhost, https://doi.org/10.1177/0300891620976981.

APA

Giulia Bianchi, Emma Zattarin, Francesca Ligorio, Federico Nichetti, Filippo de Braud, & Giuseppe Capri. (2020). Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report. Tumori Journal, 107, NP15-NP19. https://doi.org/10.1177/0300891620976981

Chicago

Giulia Bianchi, Emma Zattarin, Francesca Ligorio, Federico Nichetti, Filippo de Braud, and Giuseppe Capri. 2020. “Prolonged Benefit from Palbociclib plus Letrozole in Heavily Pretreated Advanced Male Breast Cancer: Case Report.” Tumori Journal 107 (December): NP15-NP19. doi:10.1177/0300891620976981.